相关实验视频

Updated: May 22, 2025

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

患有与α-1抗素缺乏相关的肝病的患者经验:一种定性研究

Virginia C Clark¹, Suna Park², Robert Krupnick³

¹University of Florida, Gainesville, FL, USA.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

|March 13, 2025

概括

患有α-1抗素缺乏相关性肝病 (AATD-LD) 的患者会出现显著的疲劳,呼吸问题和认知困难. 这些症状深刻影响日常生活,影响工作,活动和人际关系,突出需要更好的临床评估.

科学领域:

肝病学和遗传性肝脏疾病
患者报告的结果
肺部病理学肺部病理学

背景情况:

与α-1抗素缺乏相关的肝病 (AATD-LD) 是一种影响肝脏的遗传疾病.
了解患者的经验,包括症状和日常影响,对于综合护理至关重要.
目前的临床评估可能无法完全捕捉到AATD-LD患者的生活经验.

研究的目的:

识别和理解患有AATD-LD的患者所经历的迹象,症状和日常生活影响.
在AATD-LD.中开发患者体验的概念模型.
根据AATD-LD相关的临床结果评估的发展提供信息.

主要方法:

从文献评论,患者博客和临床医生采访中开发了一个概念列表.
对美国成年人进行一对一的概念诱导采访,诊断为AATD-LD (Pi*ZZ或Pi*MZ基因型).
根据频率和报告的烦/干扰等级 (0-10级) 定义了"最突出的"和"非常突出的"概念.

主要成果:

采访了15名患者 (平均年龄57岁).
最突出的症状包括疲劳,呼吸道感染,呼吸短促,困惑和.
最突出的影响是工作,休活动和人际关系;流动性的影响也非常突出.

结论:

几种AATD-LD的症状和影响经常被报告为麻烦.
需要对不同纤维化阶段和基因型的AATD-LD种群进行进一步的研究.
必须制定临床结果评估,以捕捉这些突出的患者报告的概念.

关键词:

阿尔法-1 抗素缺乏症概念模型是一个概念模型.疾病影响疾病的影响.遗传性肝病是一种遗传性肝病.肝脏疾病的症状肝脏疾病的症状患者的体验患者的体验

更多相关视频

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

相关概念视频

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...